Does Rythmol SR Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- SELECTED ANTIARRHYTHMICS/QUINIDINE
- PROPAFENONE/SELECTED CLASS IA AND III ANTIARRHYTHMICS
- SELECTED ANTIARRHYTHMICS/SAQUINAVIR
- SELECTED ANTIARRHYTHMICS/AMPRENAVIR; FOSAMPRENAVIR
- P-GLYCOPROTEIN (P-GP) INHIB/COLCHICINE (CARDIOPROTECTION)
- CYP1A2 INHIBITORS/FEZOLINETANT
- QT PROLONGING AGENTS/ANAGRELIDE
- QT PROLONGING AGENTS/ARTEMETHER-LUMEFANTRINE
- QT PROLONGING AGENTS/SERTINDOLE
- QT PROLONGING AGENTS/DROPERIDOL
- QT PROLONGING AGENTS/LEVOMETHADYL
- QT PROLONGING AGENTS/SPARFLOXACIN
- QT PROLONGING AGENTS/BEPRIDIL
- CLASS IA AND CLASS III ANTIARRHYTHMICS/DOFETILIDE
- SELECTED CLASS IA & III ANTIARRHYTHMICS/CISAPRIDE
- SELECTED CLASS I & III ANTIARRHYTHMICS/MIZOLASTINE
- SELECTED ANTIARRHYTHMICS/PIMOZIDE
- CLASS I AND III ANTIARRHYTHMICS/HALOFANTRINE
- SELECTED AGENTS/MIBEFRADIL
- FLECAINIDE; PROPAFENONE/NIRMATRELVIR-RITONAVIR; TIPRANAVIR
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- PROPAFENONE/QT PROLONGING AGENTS
- SELECTED CYP2D6 SUBSTRATES/MIRABEGRON
- SELECTED ANTIARRHYTHMICS/ELVITEGRAVIR-COBICISTAT
- SELECTED CYP2D6 SUBSTRATES THAT PROLONG QT/PANOBINOSTAT
- SELECTED CYP2D6 SUBSTRATES THAT PROLONG QT/GIVOSIRAN
- FLECAINIDE; PROPAFENONE/SELECTED PROTEASE INHIBITORS
- P-GLYCOPROTEIN (P-GP) INHIBITORS/VINCRISTINE
- P-GLYCOPROTEIN (P-GP) INHIBITORS/PRALSETINIB
- POSSIBLE QT PROLONGING AGENTS/LEVOKETOCONAZOLE
- P-GLYCOPROTEIN (P-GP) INHIBITORS/BILASTINE
- P-GLYCOPROTEIN (P-GP) INHIBITORS/DOXORUBICIN
- P-GP INHIBITORS/RIMEGEPANT
- P-GLYCOPROTEIN (P-GP) INHIBITORS/RELUGOLIX
- P-GP OR BCRP INHIBITORS THAT PROLONG QT/PAZOPANIB
- P-GLYCOPROTEIN (P-GP) INHIBITORS/ORAL LEFAMULIN
- WEAK CYP2D6 INHIBITORS/ELIGLUSTAT
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/VENETOCLAX
- P-GLYCOPROTEIN (P-GP) INHIBITORS/COLCHICINE
- QT PROLONGING AGENTS/CITALOPRAM
- QT PROLONGING AGENTS/TRAZODONE (>= 100 MG)
- CLASS I & CLASS III ANTIARRHYTHMICS/VERNAKALANT
- BETA-BLOCKERS; AV NODE BLOCKERS/FINGOLIMOD
- QT PROLONGING AGENTS/VANDETANIB
- QT PROLONGING AGENTS/QUININE
- QT PROLONGING AGENTS/ILOPERIDONE
- QT PROLONGING AGENTS/TOREMIFENE
- P-GLYCOPROTEIN (P-GP) INHIBITORS/TOPOTECAN
- QT PROLONGING AGENTS/ZUCLOPENTHIXOL
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/DABIGATRAN
- QT PROLONGING AGENTS/NILOTINIB
- QT PROLONGING AGENTS/PALIPERIDONE
- SELECTED ANTIARRHYTHMICS/TIZANIDINE
- QT PROLONGING AGENTS/IVABRADINE
- SELECTED QT PROLONGING AGENTS/ZIPRASIDONE
- QT PROLONGING AGENTS/MESORIDAZINE
- PROPAFENONE;FLECAINIDE/DIGOXIN
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- DISOPYRAMIDE; MEXILETINE; PROPAFENONE/RIFAMYCINS
- PROPAFENONE/FLUOXETINE
- PROPAFENONE/POSSIBLE QT PROLONGING AGENTS
- SELECTED CYP2D6 SUBSTRATES/TERBINAFINE
- POSSIBLE QT PROLONGING AGENTS/DEXMEDETOMIDINE SUBLINGUAL
- QT PROLONGING AGENTS/ETRASIMOD
- QT PROLONGING AGENTS/GEPIRONE
- QT PROLONGING AGENTS/TUCIDINOSTAT
- QT PROLONGING AGENTS/TRICLABENDAZOLE
- POSSIBLE QT PROLONGING AGENTS/PACRITINIB
- QT PROLONGING AGENTS/TOLTERODINE
- QT PROLONGING AGENTS/OZANIMOD
- QT PROLONGING AGENTS/PONESIMOD
- QT PROLONGING AGENTS/SIPONIMOD
- POSSIBLE QT PROLONGING AGENTS/FEXINIDAZOLE
- QT PROLONGING AGENTS/GALANTAMINE
- SELECTED WEAK CYP2D6 INHIBITORS/TAMOXIFEN
- POSSIBLE QT PROLONGING AGENTS/LEVOMEPROMAZINE
- POSSIBLE QT PROLONGING AGENTS/SELPERCATINIB
- POSSIBLE QT PROLONGING AGENTS/OXALIPLATIN
- QT PROLONGING AGENTS/OSILODROSTAT
- QT PROLONGING AGENTS/AMISULPRIDE
- P-GP OR BCRP INHIBITORS/UBROGEPANT
- SODIUM CHANNEL BLOCKER; POTASSIUM CHANNEL BLOCKER/LACOSAMIDE
- POSSIBLE QT PROLONGING AGENTS/ENCORAFENIB
- SELECT P-GP INHIBITORS/EDOXABAN (<= 30 MG)
- QT PROLONGING AGENTS/TRAZODONE (< 100 MG)
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/BETRIXABAN
- POSSIBLE QT PROLONGING AGENTS/RIBOCICLIB
- SELECT P-GP INHIBITORS/EDOXABAN (> 30 MG)
- POSSIBLE QT PROLONGING AGENTS/LENVATINIB
- SELECTED CYP1A2 INHIBITORS/THEOPHYLLINE DERIVATIVES
- POSSIBLE QT PROLONGING AGENTS/CERITINIB
- QT PROLONGING AGENTS/SEVOFLURANE
- QT PROLONGING AGENTS/ESCITALOPRAM
- P-GLYCOPROTEIN (P-GP) INHIBITORS/AFATINIB
- POSSIBLE QT PROLONGING AGENTS/BEDAQUILINE
- QT PROLONGING AGENTS/PASIREOTIDE
- POSSIBLE QT PROLONGING AGENTS/SORAFENIB
- QT PROLONGING AGENTS/VORICONAZOLE
- POSSIBLE QT PROLONGING AGENTS/CRIZOTINIB
- POSSIBLE QT PROLONGING AGENTS/VEMURAFENIB
- POSSIBLE QT PROLONGING AGENTS/EZOGABINE
- POSSIBLE QT PROLONGING AGENTS/GADOFOSVESET
- POSSIBLE QT PROLONGING AGENTS/ERIBULIN
- POSSIBLE QT PROLONGING AGENTS/ROMIDEPSIN
- POSSIBLE QT PROLONGING AGENTS/TELAVANCIN
- MODERATE CYP3A4; P-GP INHIBITORS/EVEROLIMUS
- QT PROLONGING AGENTS/POSACONAZOLE
- CYP3A4; CYP2C8; P-GLYCOPROTEIN (P-GP) INHIBITORS/LOPERAMIDE
- QT PROLONGING AGENTS/NORFLOXACIN
- PROPAFENONE/BETA-BLOCKERS
- PROPAFENONE/SELECTED ANTICOAGULANTS (VIT K ANTAGONISTS)
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/ETOPOSIDE
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.